_metzeler-roadtec-02-the-super-sport-touring-tyre-with-dynatread-technology.jpg "Metzeler ROADTEC 02 - The super-sport-touring tyre with DYNATREAD™ technology from medicamen bio share price Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 0:46
👁 View: 2.4M times
✓ Published: 23-Apr-2024
👁 View: 2.4M times
✓ Published: 23-Apr-2024
Description:
The Metzeler brand presents the new ROADTEC 02 tyre, a perfect mix of technology and sustainability that integrates the most recent technological innovations from the brand, redefining the benchmark for the Sport-Touring segment.<br/>ROADTEC 02 is the first tyre to use DYNATREAD™, the patented adaptive tread design technology that allows it to adapt its behaviour, from Sport-Touring to Supersport, based on the motorcyclist's riding style: to create almost a new category of tyre, the “Super-Sport-Touring”.<br/>ROADTEC 02 is made with more than 43% of bio-based and recycled materials* as certified by a third party, Bureau Veritas. The use of this type of materials also offers excellent results from a performance point of view.<br/>This new motorcycle tyre is aimed at those who use Sport Touring, Naked, Crossover, Adventure but also Supersport machines and who are looking for a tyre with a sportier appearance and performance than those of a traditional Sport-Touring without giving up good mileage and safety even on wet surfaces.
The Metzeler brand presents the new ROADTEC 02 tyre, a perfect mix of technology and sustainability that integrates the most recent technological innovations from the brand, redefining the benchmark for the Sport-Touring segment.<br/>ROADTEC 02 is the first tyre to use DYNATREAD™, the patented adaptive tread design technology that allows it to adapt its behaviour, from Sport-Touring to Supersport, based on the motorcyclist's riding style: to create almost a new category of tyre, the “Super-Sport-Touring”.<br/>ROADTEC 02 is made with more than 43% of bio-based and recycled materials* as certified by a third party, Bureau Veritas. The use of this type of materials also offers excellent results from a performance point of view.<br/>This new motorcycle tyre is aimed at those who use Sport Touring, Naked, Crossover, Adventure but also Supersport machines and who are looking for a tyre with a sportier appearance and performance than those of a traditional Sport-Touring without giving up good mileage and safety even on wet surfaces.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_meta-stock-plummets-15-as-market-reacts-to-increased-ai-spending.webp "Meta's stock price fell 15% when markets opened on Thursday, wiping $190 billion off its market value. This was in reaction to Meta's pledge to increase spending on artificial intelligence technologies significantly. Meta CEO Mark Zuckerberg said AI spending would need to \")
_90000-loss-medicamen-medicamen-biotech-share-latest-news124why-medicamen-biotech-share-falling-124.webp "Stocks Advisor")
⏲ 9 minutes 5 seconds 👁 962
_didyouknow-medicamen-biotech-june-23-2017.webp "CNBC-TV18")
_stock-analysis-of-medicamen-biotech-why-stock-is-falling.webp "Pratap Patil")
_medicamen-biotech-ltd124medicamen-biotech-ltd-share-latest-news.webp "katariya fundamental")
_microsoft-backed-rubrik-surpasses-expectations-with-ipo-pricing-at-3632-per-share.webp "Data management software company Rubrik priced its IPO at $32 per share, above its expected range. The company raised $752 million by selling 23.5 million shares in its debut on the NYSE, valuing Rubrik at $5.6 billion. Rubrik provides cloud-based cybersecurity software for data protection, backup and recovery, and ransomware prevention. Major backers include Microsoft, which invested in 2021, and Lightspeed Venture Partners, which will retain over 25% voting power. Rubrik is one of the first notable tech IPOs of 2024 following Reddit and Astera Labs earlier this year.")
_medicamen-biotech-124-microcapstocks-financialanalysis-pharma.webp "Shares Kare Stock")
_meta-stock-plummets-15-as-market-reacts-to-increased-ai-spending.jpg)
_90000-loss-medicamen-medicamen-biotech-share-latest-news124why-medicamen-biotech-share-falling-124.jpg)
_didyouknow-medicamen-biotech-june-23-2017.jpg)
_stock-analysis-of-medicamen-biotech-why-stock-is-falling.jpg)
_medicamen-biotech-ltd124medicamen-biotech-ltd-share-latest-news.jpg)
_microsoft-backed-rubrik-surpasses-expectations-with-ipo-pricing-at-3632-per-share.jpg)
_medicamen-biotech-124-microcapstocks-financialanalysis-pharma.jpg)
![[+]](/images/menu.gif){kind=small}